id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4844-0002,FDA,FDA-2019-N-4844,Barry Callebaut USA LLC,Other,Letter(s),2020-02-12T05:00:00Z,2020,2,2020-02-12T05:00:00Z,,2020-02-12T17:48:54Z,,0,0,090000648435bc12